Refresh

Fredun Pharmaceuticals Ltd. - Research Center

539730 FREDUN Group (X) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

274.68 224.46 133.89 112.77 97.02
Expenses

Material consumed

208.69 177.11 102.25 80.81 59.88

Manufacturing expenses

9.58 7.15 4.77 5.29 4.22

Personnel expenses

11.53 10.66 8.66 8.95 8.04

Selling expenses

0.10 0.18 - 0.04 0.24

Adminstrative expenses

17.00 15.56 9.08 9.42 14.43

Expenses capitalised

- - - - -

Cost of sales

246.90 210.66 124.75 104.50 86.81

Operating profit

27.78 13.80 9.14 8.27 10.20

Other recurring income

1.82 1.63 1.40 0.52 0.39

Adjusted PBDIT

29.60 15.43 10.54 8.79 10.59

Financial expenses

9.28 4.67 4.16 4.41 3.10

Depreciation

2.81 2.16 2.00 1.88 1.33

Other write offs

- - - - -

Adjusted PBT

17.51 8.60 4.37 2.49 6.16

Tax charges

6.70 2.26 1.19 0.59 1.70

Adjusted PAT

10.81 6.34 3.18 1.90 4.46

Non recurring items

0.05 -0.02 -1.16 - -

Other non cash adjustments

- - - - -

Reported net profit

10.86 6.31 2.02 1.90 4.46

Earnigs before appropriation

28.86 18.24 12.19 9.75 8.16

Equity dividend

0.31 0.31 0.27 - 0.21

Preference dividend

- - - - -

Dividend tax

- - - - 0.05

Retained earnings

28.55 17.93 11.93 9.75 7.90
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com